ACADIA Pharmaceuticals Inc. provided sales guidance for the full year 2024. The company providing net sales guidance between $560 million and $590 million for 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.84 USD | -0.30% | -3.11% | -52.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.71% | 2.46B | |
+47.17% | 57.87B | |
+41.14% | 40.25B | |
-6.89% | 39.94B | |
-5.16% | 28.54B | |
+11.54% | 26.4B | |
-20.60% | 19.33B | |
+30.00% | 12.4B | |
-0.87% | 12.23B | |
+24.36% | 12.2B |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.
- ACADIA Pharmaceuticals Inc. Provides Sales Guidance for the Full Year 2024